Boxer Capital’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SWTX
DTC
BCM
MC
Boxer Capital's SWTX Position: Q4 2024 in Review
Boxer Capital sold out of SpringWorks Therapeutics (SWTX) in Q4 2024, closing a stake of 3,421,541 shares — an estimated $110M sold.
Boxer Capital first reported a position in SWTX in Q3 2019 and held it in 21 quarters. The position peaked at $171M in Q2 2021. 216 funds tracked by Wall St. Rank hold SWTX as of Q4 2024.
- Boxer Capital reported no remaining SpringWorks Therapeutics position as of Q4 2024 after selling out during the quarter.
- Boxer Capital sold 3,421,541 SpringWorks Therapeutics shares in Q4 2024, an estimated $110M.
- Boxer Capital first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 21 quarters.
- Boxer Capital's SpringWorks Therapeutics position peaked at $171M in Q2 2021.
- 216 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q4 2024.
Based on Boxer Capital's 13F filing for Q4 2024.